BR vs BTAI · P/E 16, rev $7.48B vs rev $388.0K
Broadridge Financial Solutions Inc (BR) versus BioXcel Therapeutics Inc (BTAI) — a side-by-side from cached financials, not a winner call.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
BR currently screens at market cap $17.65B and trailing P/E 16.3. BTAI currently screens at market cap $36.1M.
Not investment advice. Open the BR and BTAI stock pages for the full models.
Not investment advice.